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Abstract The dynamics of cell renewal in the normal adult
liver remains an unresolved issue. We investigate the possible
contribution of a common biliary precursor cell pool to hepa-
tocyte turnover in the chimeric long-term repopulated rat liver.
The retrorsine (RS)-basedmodel ofmassive liver repopulation
was used. Animals not expressing the CD26 marker (CD26-)
were injected with RS, followed by transplantation of 2 mil-
lion syngeneic hepatocytes isolated from a normal CD26-
expressing donor. Extensive (80-90 %) replacement of resi-
dent parenchymal cells was observed at 1 year post-
transplantation and persisted at 2 years, as expected. A panel
of specific markers, including cytokeratin 7, OV6, EpCAM,
claudin 7 andα-fetoprotein, was employed to locate the in situ
putative progenitor and/or biliary epithelial cells in the stably
repopulated liver. No overlap was observed between any of
these markers and the CD26 tag identifying transplanted cells.
Exposure to RS was not inhibitory to the putative progenitor
and/or biliary epithelial cells, nor did we observe any evidence
of cell fusion between these cells and the transplanted cell
population. Given the long-term (>2 years) stability of the
donor cell phenotype in this model of liver repopulation, the
present findings suggest that hepatocyte turnover in the
repopulated liver is fuelled by a cell lineage distinct from that
of the biliary epithelium and relies largely on the differentiated
parenchymal cell population. These results support the solid
biological foundation of liver repopulation strategies based on
the transplantation of isolated hepatocytes.
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Introduction
The liver exhibits slow parenchymal cell turnover. Estimates
of the average lifespan of hepatocytes under non-perturbed
conditions are in the range of 1 year, although the exact
quantification of this parameter has been elusive so far, par-
ticularly in the human liver (MacDonald 1961; Ponder 1996;
Imai et al. 2001). Paradoxically, the liver is also endowed with
a proliferative capacity, as exemplified both clinically and
experimentally by the intense regenerative response that fol-
lows partial surgical hepatectomy. Indeed, the ability to com-
pensate for cell loss is an important functional feature of
hepatocytes, given their potential physiological exposure to
diet-related toxic and metabolic insults (Alison 1986;
Michalopoulos 2010).
In spite of its relevance to liver physiology, the source of
hepatocyte turnover remains an unsettled issue. The
large majority of differentiated hepatocytes are neverthe-
less known to be capable of undergoing cell division
following massive tissue loss, implying that a special-
ized tissue niche devoted to hepatocyte renewal is not
needed (Duncan et al. 2009). On the other hand, several
lines of evidence indicate that hepatocytes can be gen-
erated from progenitor cell populations when the repli-
cative capacity of the resident differentiated compart-
ment is impaired or exhausted, thus supporting the
contention that a precursor cell type for hepatocytes
does indeed exist in the adult liver, including normal
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human liver (Schmelzer et al. 2007; Semeraro et al.
2012; Español-Suñer et al. 2012). However, the biolog-
ical mechanisms involved in the continuous, albeit slow,
daily replenishment of lost hepatocytes under normal
steady-state conditions remains to be firmly established.
Almost 30 years ago, Zajicek et al. (1985) proposed
the streaming liver hypothesis, which postulates that
hepatocytes are normally generated in the periportal
space of the liver acinus (zone 1) and move slowly
along the sinusoids to end up and die in the pericentral
area (zone 3). The entire journey has been estimated to last
about 1 year, based on data derived from the analysis of
normal rat liver.
Subsequent studies have not been supportive of the above
proposition. For example, Bralet et al. (1994) observed no
evidence of migratory behavior in retrovirally tagged hepato-
cytes after 1 year of follow up in rats and similar results have
been reported in mice (Kennedy et al. 1995). Based on these
findings, the hypothesis of hepatocyte streaming has become
less attractive, although recent evidence provided by
Furuyama et al. (2011) has reawakened interest in this con-
cept. The normal turnover of mouse hepatocytes has been
suggested to be sustained by intrahepatic biliary epithe-
lial cells and to follow a pattern consistent with the
continuous streaming of parenchymal cells from the
periportal area to the central hepatic vein, with an
overall transit time of about 1 year. Data compatible with a
migratory behavior of hepatocytes along the sinusoidal direc-
tion of blood flow had also been obtained in earlier studies
conducted on human liver (Fellous et al. 2009). The results of
Furuyama et al. (2011) have however been recently
questioned (Malato et al. 2011).
Given these conflicting findings and considering the
relevance of this issue to the field of regenerative med-
icine (Alison et al. 2012), we explore the origin of
hepatocyte turnover in a model of massive liver repopu-
lation. In rats exposed to retrorsine (RS) and then
injected with normal syngeneic hepatocytes, near-total
replacement of the resident parenchyma by donor-
derived cells is observed (Laconi et al. 2001). Notably,
liver repopulation in this system is stable, persisting for
at least 2 years after cell transplantation (Laconi et al.
2006). The latter observation is important, because it
implies that any rate of hepatocyte turnover in these
animals must be sustained by cells of donor origin,
irrespective of their specific phenotype. Furthermore, if
hepatocyte streaming does occur in the repopulated liver,
it should be fuelled by a donor-derived precursor cell
pool. The present studies were designed to test the above
possibilities. The results indicate the hepatocyte turnover
is sustained by a cell lineage distinct from that of the
biliary epithelium and relies largely on the transplanted
differentiated parenchymal cell population.
Materials and methods
Animals and treatments
The dipeptidyl-peptidase-deficient (DPPIV-) Fischer 344 rat
model (Thompson et al. 1991) was used for transplantation
experiments. A colony of DPPIV- animals was available in the
animal room at the University of Cagliari, whereas donor
DPPIV+ F344 rats were purchased from Charles River, Italy.
All animals were maintained under alternating 12 h light/dark
daily cycles and were fed ad libitumwith Rodent Chow Diet.
Experiments were approved by the University of Cagliari
Ethical Committee for Animal Experimentation and were in
accordancewith NIHGuidelines for the care and use of animals
(NIH publication 86–23, revised 1985). Six-week-old DPPIV-
rats (with a body weight of 70-90 g) were treated with two i.p.
injections of either 30 mg/kg RS (Sigma) or saline, 2 weeks
apart. Four weeks after the last injection of RS, eight animals
were transplanted, via the portal circulation, with 2 million
normal hepatocytes isolated from a DPPIV+ donor. Groups of
four rats each were killed 1 or 2 years after cell transplantation.
Another group of four rats was given RS only and was killed 1
year later. Livers were excised and samples from each lobe
were either snap-frozen (for cryostat sections) or fixed in 10 %
buffered formalin and embedded in paraffin.
Histochemical determination of DPPIV enzyme activity
and quantitation of percent repopulation were performed as
described (Laconi et al. 2001) on three samples taken from
each lobe.
In a parallel study, groups of 4 control and 4 RS-treated
animals did not receive hepatocyte transplantation and were
subjected to 2/3 partial hepatectomy (PH) 4 weeks after the
initial treatment. All rats were killed 48 h post-PH; each
animal was injected with 5′-bromo-deoxyuridine (BrdU,
50 mg/kg, i.p.), starting at 20 h post-surgery and every 8 h
until being killed. The uptake of BrdU was expressed as the
percent of labeled cells. At least 20 biliary ducts were scored
in each animal.
Hepatocyte isolation and transplantation
Hepatocytes for transplantation were isolated from a 6-week-
old DPPIV+syngeneic F344 rat according to a standard two-
step collagenase perfusion technique (Berry and Friend 1969;
Seglen 1976). Cell viability was >85 % as assessed by trypan
blue dye exclusion. Hepatocytes were suspended in
phosphate-buffered saline (PBS; 1×107/ml) and delivered
through a branch of the mesenteric veins.
Immunohistochemistry and immunofluorescence
Immunohistochemical staining for DPPIV/CD26 was per-
formed on formalin-fixed sections following antigen retrieval
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in boiling citrate buffer (0.1 M, pH 6) for 15 min. Sections
were then incubated with the primary antibody (BD, San Jose,
Calif., USA) overnight at 4 °C and then with alkaline-
phosphatase-conjugated secondary antibody. Detection of a
specific signal was accomplished by using the avidin/biotin/
alkaline phosphatase system (Vectastain ABC kit; Vector
Labs, Burlingame, Calif., USA). Immunohistochemical
staining for Ki67 was carried out on 5-μm-thick frozen
sections fixed in 0.1 % acetic acid/ethanol, washed in PBS
and blocked with goat serum. Primary antibody (Abcam,
Cambridge, Mass., USA) was applied overnight at 4 °C
and then samples were processed as described for paraffin
sections.
Immunofluorescent staining was performed on 5-μm-thick
frozen sections that had been fixed for 10 min in cold acetone.
Primary antibodies were: cytokeratin 7 (CK7), EpCAM, α-
fetoprotein (αFP), Claudin 7, Ki67 (Abcam), DPPIV/CD26,
BrdU (Dako, Denmark) and OV6 (kindly provided by Dr.
Dabeva). Slides were blocked with goat serum, incubated with
primary antibodies for 1 h at room temperature, followed by
incubation for 45 min with fluorescent-conjugated secondary
antibodies (Dylight 488, Abcam; Alexa Fluor 555, Life
Technologies, Grand Island, N.Y., USA). Slides were finally
covered with Vectashield mounting medium with 4,6-
diamidino-2-phenylindole (DAPI; 1 μl/ml; Vector Labs,
UK) to visualize cell nuclei. Images were acquired with an
IX71 fluorescence microscope with a charge-coupled device
camera (Olympus, Tokyo, Japan).
One to three samples were taken from each liver lobe. All
sections were thoroughly screened for the expression of the
relevant markers (see above).
Enzyme histochemistry
Histochemical determination of DPPIV enzyme activity was
performed as described by Laconi et al. (2001). Briefly, cryo-
stat sections were fixed in 0.1 % acetic acid/ethanol, air-dried
and incubated for 15 min at room temperature with the sub-
strate reagent, namely 2.5 mg Gly-Pro-4-methoxy-β-
naphthylamide dissolved in 150 μl dimethylformamide and
then mixed with 5 ml of a solution of Fast blue BB salt
(1 mg/ml in PBS). All reagents were purchased from Sigma.
Results
Transplanted cells do not replace resident bile ductular
epithelium
As previously mentioned, the main version of the streaming
liver hypothesis posits that hepatocytes originate near the
periportal space from a precursor pool that is shared with the
epithelium of the biliary tree. To test this possibility, the origin
of such a putative common precursor cell compartment was
analyzed in the repopulated liver. We first confirmed and
extended our earlier observation concerning the stability of
the donor hepatocyte phenotype in the RS-exposed and
repopulated liver (Laconi et al. 2006). As shown in Fig. 1,
80-95 % repopulation of the RS-treated DPPIV- rat liver by
DPPIV+ donor-derived hepatocytes was observed as late as 24
months post-transplantation (Fig. 1a, b). Similar results were
seen in animals killed after 1 year (data not presented). The
rate of hepatocyte turnover in the repopulated liver was eval-
uated through the immunohistochemical detection of Ki67
antigen. Rare labeled hepatocytes (about 1/5000) were seen
throughout the liver parenchyma, with no apparent zonal
distribution (Fig. 1c). Interestingly, biliary epithelial cells in
periportal areas did not express the DPPIVenzyme (Fig. 1a, b)
indicating that they retained the host phenotype and were not
replaced by donor-derived cells.
The latter finding was then explored in greater detail by
using a panel of immunohistochemical markers for the in situ
detection of biliary epithelial cells and/or putative hepatocyte
progenitor cells in the repopulated liver. Markers included
CK7, OV6, EpCAM, claudin 7 and α-FP (Figs. 2, 3).
Positive staining for claudin 7 was observed in periportal bile
ducts and in rare isolated cells within the lobule of repopulated
livers in animals killed 1 year after hepatocyte trans-
plantation (Fig. 2a). Extensive liver repopulation was
documented by the diffuse expression of CD26/DPPIV en-
zyme, a marker of donor-derived cells (Fig. 2b). No overlap
was seen between CD26- and claudin-positive cells (Fig. 2c)
indicating that the latter were of recipient origin. This conclu-
sion was supported by the co-expression of CD26 and claudin
7 in the bile ductular epithelium of DPPIV-positive Fischer
rats (Fig. 2g–i).
Similar findings were observed following immunofluores-
cent staining for α-FP (Fig. 2d–f), OV6 (Fig. 3a), CK7
(Fig. 3b) and EpCAM (Fig. 3g). All markers were expressed
by the periportal biliary epithelium and by isolated cells or
small cell clusters dispersed in the liver lobule, although CK7
appeared to be specific for large bile ducts. No overlap
between any of these markers and CD26 was observed.
On the other hand, the large majority of surrounding
hepatocytes expressed CD26, confirming their origin
from donor-derived cells (Fig. 2b, c, e, f, Fig. 3c, h, i).
Importantly, claudin 7, α-FP, OV6, CK7 and EpCAM were
each co-expressed with CD26 in the bile ductular epi-
theliums of DPPIV-positive animals, as expected (Fig. 2g–l,
Fig. 3d–f, j–l).
Exposure to RS does not inhibit proliferation of bile ductular
epithelium
The findings described above rule out the involvement of
a common biliary precursor pool in sustaining hepatocyte
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turnover in the RS-treated and repopulated liver. One
possible explanation for this result would be that RS
inhibits the proliferation of bile ductular epithelium. We
therefore tested this possibility in rats subjected to 2/3 partial
hepatectomy following exposure to RS. Immunohistochemical
staining for the uptake of BrdU revealed comparable
levels of staining in the biliary epithelium from RS-
treated and control animals (Fig. 4a–c) suggesting that no
Fig. 1 Stability of donor-derived phenotype in retrorsine (RS)-treated
repopulated liver. a, b Immunohistochemical staining for DPPIV/CD26
antigen in the liver of a RS-treated DPPIV- rat transplanted with hepato-
cytes isolated from a DPPIV+ syngenic donor. The sample was taken 2
years after cell transplantation. Note the persistent replacement of the
DPPIV- host liver by DPPIV-expressing hepatocytes (dark blue), with the
typical chicken-wire pattern associated with this enzyme protein. Bile
ductular epithelium (b arrow) does not express DPPIVand maintains the
original host phenotype. cSection of liver sample from the same group of
animals and stained for histochemical detection of DPPIV (orange-rust)
and expression of Ki67 antigen (immunohistochemistry, dark blue). Note
the presence of scattered rare nuclei positive for the cell cycle marker
(arrows). Bars 200 μm (a), 50 μm (b, c)
Fig. 2 Claudin 7 (Clau7)- or α-
do not express the CD26 donor
cell marker (blue nuclear staining
with DAPI). Dual
immunohistochemical staining
for either claudin 7 (a–c) or αFP
(d–f) and DPPIV/CD26
(CD26) in the liver of RS-treated
DPPIV- rat transplanted with
hepatocytes isolated from a
DPPIV+ syngenic donor
(+Tx plus transplant). Samples
were taken 1 year post-
transplantation. No overlap was
observed between DPPIV/CD26
expression and staining for
claudin 7 or αFP. Note the
extensive repopulation of the
host liver (green) around claudin
7- or αFP-expressing cells. For
comparison, g–l show co-
expression of DPPIV/CD26 in
claudin 7- or αFP-positive cells
from normal untreated DPPIV+
rats. Bars 100 μm
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fetoprotein (αFP)-positive cells
specific inhibitory effect was exerted by RS on the bile
ductular cell cycle.
Hepatocyte fusion with putative progenitor cells is not a major
factor in RS-induced liver repopulation
Cell fusion is considered to occur physiologically in the liver
(Wang et al. 2003; Quintana-Bustamante et al. 2006; Faggioli
et al. 2008). However, the possible contribution of this process
to liver repopulation remains a debated issue. Given the sta-
bility of the donor hepatocyte phenotype in the RS-treated and
repopulated liver, one can still postulate that putative endog-
enous progenitor cells (DPPIV-) might be involved in hepato-
cyte turnover through fusion with differentiated transplanted
hepatocytes (DPPIV+), resulting in the prevalence of the latter
phenotype. To address this possibility directly, we reversed the
phenotype of the donor and the recipient animals by
transplanting DPPIV- hepatocytes into RS-treated DPP-IV+
hosts. Under these conditions, one would expect a prevalent
DPPIV+ phenotype among the hepatocytes of the repopulated
liver, if indeed cell fusion had a prominent role during the
process. However, the observed results did not support this
possibility. We found instead that the RS-treated DPPIV+ host
liver was extensively repopulated by donor-derived cells ex-
pressing their original DPPIV- phenotype (Fig. 4d). This
indicated that fusion of transplanted hepatocytes with
putative endogenous progenitor cells was not a promi-
nent phenomenon, if indeed it occurred at all. Scattered
areas of host-derived (DPPV+) hepatocytes were also
present, possibly representing endogenous regenerative
nodules, which are known to occur in RS-treated liver
(McLean 1970; (Fig. 4d, left box, enlarged in e). The
results presented also indicated that hepatocyte trans-
plantation in RS-exposed rats replaced only the paren-
chymal component of the liver, whereas other cell types,
including bile ductular epithelium, were still of recipient ori-
gin and expressed the DPPIV enzyme marker (Fig. 4d, right
box, enlarged in f).
Fig. 3 OV6-, CK7-, or EpCAM-
positive cells do not express the
CD26 donor cell marker. a–c
Immunofluorescence staining for
OV6, CK7 and DPPIV/CD26,
respectively, on serial sections
obtained from RS-treated
DPPIV- rat liver transplanted with
hepatocytes isolated from a
DPPIV+ syngenic donor. Samples
were taken 1 year post-
transplantation. Note that
OV6- and/or CK7-positive cells
do not express the donor DPPIV/
CD26 marker. d–f
Immunofluorescence staining for
OV6, CK7 and DPPIV/CD26,
respectively, on serial sections
obtained from untreated DPPIV+
rat liver. Note that both OV6- and
CK7-positive cells also express
DPPIV/CD26 antigen. g–iDual
immunohistochemical staining
for EpCAM and DPPIV/CD26 in
the liver of RS-treated DPPIV- rat
transplanted with hepatocytes
isolated from a DPPIV+ syngenic




staining for EpCAM. For
comparison, j–l show co-
expression of DPPIV/CD26 in
EpCAM-positive cells from
normal untreated DPPIV+ rats.
Bars 100 μm
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Discussion
Taken together, our present findings support the conclusion
that long-term hepatocyte turnover in the repopulated rat liver
is largely fuelled by differentiated transplanted cells of donor
origin and that the cell lineage is distinct from that of the
biliary epithelium. This conclusion is based on the following:
(1) the donor-cell phenotype of the repopulated liver remains
stable over at least 2 years, as previously shown (Laconi et al.
2006) and as confirmed by the present studies; (2) the
transplanted cells replace only the parenchymal component
(hepatocytes) of the host liver, whereas other cell types, in-
cluding biliary epithelium, remain of recipient origin; (3) no
cross-reactivity can indeed be documented between the donor
cell marker (DPPIV/CD26) and a panel of markers specific for
biliary epithelium and/or putative progenitor cells in the
repopulated rat liver; (4) no evidence of cell fusion between
transplanted hepatocytes and putative endogenous progenitor
cells has been observed.
The rate of hepatocyte turnover under normal steady-state
conditions has been difficult to assess: estimates in rodent
liver vary between 200 and 450 days but they have been as
high as 3000 days (MacDonald 1961; Ponder 1996; Imai et al.
2001). The general agreement is that hepatocytes are long-
lived cells, despite their enormous potential to replicate in
response to appropriate stimuli (MacDonald 1961; Ponder
1996; Imai et al. 2001; Alison 1986; Michalopoulos 2010).
Our present data on the extent of Ki67 labeling in hepatocytes
Fig. 4 No evidence of cell fusion during RS-induced liver repopulation.
a–c RS does not inhibit proliferation of bile ductular epithelial cells
(arrowheads dividing cells). Immunohistochemical staining for 5′-bro-
mo-deoxyuridine (BrdU) uptake in liver sections obtained from control
(a) or RS-treated rats (b) at 2 days after partial hepatectomy (PH).
Quantitation of BrdU-labeling index is shown in c. Original magnification
200×. d–fNo evidence of cell fusion during RS-induced liver repopula-
tion. Histochemical staining for DPPIV enzyme activity (orange-rust) in
the liver of a RS-treated DPPIV+ rat transplanted with hepatocytes
isolated from a DPPIV- syngenic donor. The sample was taken 1 year
after cell transplantation. The DPPIV+ host liver was extensively
repopulated by DPPIV- hepatocytes (d). However, non-parenchymal
cells, including bile ductular epithelium (arrows), maintained the original
phenotype of the host liver and expressed DPPIV (left box in d, enlarged
in e). Isolated areas of DPPIV-expressing hepatocytes were also observed,
possibly representing endogenous regenerative nodules (arrowheads,
right box in d, enlarged in f). Bars 50 μm (a, b, e, f), 200 μm (d)
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in the stably repopulated rat liver are in agreement with this
conclusion, confirming the low proliferative rate of this tissue
in the adult/aged animal.
In these studies, we also ruled out the possibility that treat-
ment with RS impairs the replicative potential of a putative
common precursor cell pool, thereby preventing its contribu-
tion to hepatocyte turnover. Unlike genetically based models of
liver repopulation, such the urokinase-plasminogen-activator
(uPA) transgenic mouse (Rhim et al. 1994) and the fumaryl-
acetoacetate-hydroxylasae (FAH) defective mouse (Overturf
et al. 1996), RS-treated animals bear no driver alterations in
the germ line. Thus, cell types in the liver, other than hepato-
cytes, need not be affected by RS in their proliferative capacity.
Not surprisingly, we observed that cells expressing the biliary
epithelium exhibit a similar response to PH in both RS-treated
and control rats, indicating no direct inhibitory effect of the
alkaloid on the proliferation of these cells. In this context, we
should also take into consideration that exposure to pyrrolizi-
dine alkaloids, including RS, has long been associated with the
emergence of liver regenerative nodules (McLean 1970;
Schoental andMagee 1959). The cell of origin of these nodules
is still debated, with at least three different hypothesis having
been proposed (Best and Coleman 2007; Pichard et al. 2009;
Chen et al. 2013); however, their presence per se indicates that
RS does not suppress the activation of a progenitor cell com-
partment that is indeed able slowly to replace RS-induced
megalocytes in a process that we have referred to as endoge-
nous repopulation (Laconi et al. 2008). As is apparent from the
present studies, transplanted hepatocytes expressing a fully
differentiated phenotype are able to outrun the growth of the
endogenous progenitor cell pool following RS-induced injury,
resulting in the long-term repopulation of the host liver with a
donor-derived phenotype.
Finally, we addressed the possible involvement of cell
fusion between donor and recipient cells during hepatocyte
turnover of the repopulated liver. Several reports have docu-
mented the occurrence of both homotypic (Faggioli et al.
2008) and heterotypic (Wang et al. 2003; Quintana-
Bustamante et al. 2006) fusion events in the liver. Thus, the
possibility that putative endogenous progenitor cells could
fuse with transplanted hepatocytes, generating hybrid
heterocaryons of mixed phenotype, had to be tested. To this
end, we reversed the donor and recipient phenotypes in the
DPPIV model of hepatocyte transplantation, i.e., we
transplanted DPPIV-deficient hepatocytes into RS-treated
DPPIV+ host livers. We observed that the recipient parenchy-
ma was efficiently repopulated by transplanted hepatocytes
and that the latter maintained the donor-derived DPPIV- phe-
notype. We also confirmed that non-parenchymal cells, in-
cluding bile ductular epithelium, were not replaced by the
transplanted cell population, indicating that the RS-induced
process of liver repopulation is largely tissue-specific
(Michalopoulos et al. 2005).
In summary, our present results indicate the presence of two
distinct cell lineages sustaining hepatocyte and biliary cell
turnover in the repopulated liver. In light of these findings,
the long-term stability (>2 years) of the donor-derived pheno-
type in this model of liver repopulation is consistent with a
continuous, albeit extremely slow, generation of new hepato-
cytes from the transplanted differentiated cell population.
Remarkably, this occurs in spite of the presence of an endog-
enous RS-induced pool of progenitor cells (Schoental and
Magee 1959; Best and Coleman 2007; Pichard et al. 2009;
Chen et al. 2013; Laconi et al. 2008).
To our knowledge this is the first study exploring the origin
of hepatocyte turnover in a long-term, stably repopulated liver.
With respect to the relevance of this issue to the field of
regenerative medicine, these results support the solid biolog-
ical foundation of liver repopulation strategies based on the
transplantation of isolated hepatocytes.
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